Differences between the pathogenesis of senile plaques and congophilic angiopathy in alzheimer disease

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 7, 1997, Pages 751-761

  Verbeek, Marcel M ^a   Eikelenboom, Piet ^b   De Waal, Robert M W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Acute phase; Alzheimer disease; Amyloid protein; Cerebrovascular amyloidosis; Congophilic angiopathy; Pathogenesis; Senile plaques

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CONGO RED;

ALZHEIMER DISEASE; CEREBROVASCULAR DISEASE; COMPLEMENT FACTOR; HUMAN; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SENILE PLAQUE;

EID: 0031011209     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199756070-00001     Document Type: Review

References (88)

1. Selkoe DJ. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol 1994;10:373-403
2. Levy E, Carman MD, Fernandez-Madrid IJ, et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990;248:1124-26
3. Mandybur TI. The incidence of cerebral amyloid angiopathy in Alzheimer's disease. Neurology 1975;25:120-26
4. Murphy GMJ, Forno LS, Higgins L, Scardina JM, Eng FL, Cordell B. Development of a monoclonal antibody specific for the COOH-terminal of β-amyloid 1-42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders. Am J Pathol 1994;144:1082-88
5. 42 in cerebrovascular deposits. Amyloid. Int J Exp Clin Invest 1995;2:234-40
6. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific monoclonals: Evidence that an initially deposited species is Aβ42(43). Neuron 1994;13:45-53
7. 42(43). Neurodegeneration 1996;5:115-20
8. Iwatsubo T, Saido TC, Mann DMA, Lee VM-Y, Trojanowski JQ. Full-length amyloid-β(1-42[43]) and amino-terminally modified and truncated amyloid-β42(43) deposit in diffuse plaques. Am J Pathol 1996;149:1823-30
9. 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am J Pathol 1996;148:1257-66
10. Gravina SA, Ho L, Eckman CB, et al. Amyloid protein (Aβ) in Alzheimer's disease brain. J Biol Chem 1995;270:7013-16
11. Iwatsubo T, Mann DMA, Odaka A, Suzuki N, Ihara Y. Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann Neurol 1995;37:294-99
12. Roher AE, Lowenson JD, Clarke S, et al. β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: Implications for the pathology of Alzheimer disease. Proc Natl Acad Sci USA 1993;90:10836-40
13. 42(43). Ann Neurol 1996;40:149-56
14. Mann DMA, Iwatsubo T, Nochlin D, Sumi SM, Levy-Lahad E, Bird TD. Amyloid (Aβ) deposition in chromosome 1-linked Alzheimer's disease: The Volga German families. Ann Neurol 1997;41:52-57
15. Scheuner D, Eckman C, Jensen M, et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med 1996;2:864-70
16. Hendriks L, van Duijn CM, Cras P, et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nature Genet 1992;1:218-21
17. Lemere CA, Lopera F, Kosik KS, et al. The E280Aβ presenilin 1 Alzheimer mutation produces increased β42 deposition and severe cerebellar pathology. Nature Med 1996;2:1146-50
18. Borchelt DR, Thinakaran G, Eckman CB, et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ration in vitro and in vivo. Neuron 1996;17:1005-13
19. Suzuki N, Cheung TT, Cai X-D, et al. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (APP717) mutants. Science 1994;264:1336-40
20. Barrow CJ, Zagorski MG. Solution structures of β peptide and its constituent fragments: Relation to amyloid deposition. Science 1991;253:179-82
21. Jarrett JT, Berger EP, Lansbury PT. The carboxy terminus of the amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993;32:4693-97
22. Uéda K, Fukushima H, Masliah E, et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 1993;90:11282-86
23. Vitek MP, Bhattacharya K, Glendening JM, et al. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 1994;91:4766-70
24. Johnson SA, McNeill T, Cordell B, Finch CE. Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. Science 1990;248:854-57
25. Tate-Ostroff B, Majocha RE, Marotta CA. Identification of cellular and extracellular sites of amyloid precursor protein extracytoplasmic domain in normal and Alzheimer disease brains. Proc Natl Acad Sci USA 1989;86:745-49
26. Shoji M, Hirai S, Yamaguchi H, Harigaya Y, Kawarabayashi T. Amyloid β-protein precursor accumulates in dystrophic neurites of senile plaques in Alzheimer-type dementia. Brain Res 1990;512:164-68
27. Haga S, Akai K, Ishii T. Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. Acta Neuropathol 1989;77:569-75
28. Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 1989;24:173-82
29. Wegiel J, Wisniewski HM. The complex of microglial cells and amyloid star in three-dimensional reconstruction. Acta Neuropathol 1990;81:116-24
30. Akiyama H, McGeer PL. Brain microglia constitutively express β-2 integrins. J Neuroimmunol 1990;30:81-93
31. Verbeek MM, Otte-Höller I, Wesseling P, et al. A lysosomal marker for activated microglial cells involved in Alzheimer classic senile plaques. Acta Neuropathol 1995;90:493-503
32. Shaffer LM, Dority MD, Gupta-Bansal R, Frederickson RCA, Younkin SG, Brunden KR. Amyloid β protein (Aβ) removal by neuroglial cells in culture. Neurobiol Aging 1995;16:737-45
33. Cotman CW, Tenner AJ, Cummings BJ. β-Amyloid converts an acute phase injury response to chronic injury responses. Neurobiol Aging 1996;17:723-31
34. Mattiace LA, Davies P, Yen S-H, Dickson DW. Microglia in cerebellar plaques in Alzheimer's disease. Acta Neuropathol 1990;80:493-98
35. Frackowiak J, Zoltowska A, Wisniewski HM. Non-fibrillar β-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease. J Neuropathol Exp Neurol 1994;53:637-45
36. Yamaguchi H, Yamazaki T, Lemere CA, Frosch MP, Selkoe DJ. Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. Am J Pathol 1992;141:249-59
37. Shoji M, Hirai S, Harigaya Y, Kawarabayashi T, Yamaguchi H. The amyloid β-protein precursor is localized in smooth muscle cells of leptomeningeal vessels. Brain Res 1990;530:113-16
38. Davis-Salinas J, Saporito-Irwin SM, Cotman CW, Van Nostrand WE. Amyloid β-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J Neurochem 1995;65:931-34
39. Fukuchi K, Ho L, Younkin SG, et al. High levels of circulating β-amyloid peptide do not cause cerebral β-amyloidosis in transgenic mice. Am J Pathol 1997;149:219-27
40. Verbeek MM, Otte-Höller I, Wesseling P, Ruiter DJ, de Waal RMW. Induction of β-smooth muscle actin expression in cultured human brain pericytes by TGF 1. Am J Pathol 1994;144:372-82
41. Verbeek MM, de Waal RMW, Schipper JJ, Van Nostrand WE. Rapid degeneration of cultured human brain pericytes by amyloid β protein. J Neurochem 1997;68:1135-41
42. Graeber MB, Streit WJ, Büringer D, Sparks L, Kreutzberg GW. Ultrastructural location of major histocompatibility complex (MHC) class II positive perivascular cells in histologically normal human brain. J Neuropathol Exp Neurol 1992;51:303-11
43. Wisniewski HM, Wegiel J, Wang KC, Lach B. Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol 1992;84:117-27
44. Maat-Schieman MLC, Rozemuller AJ, van Duinen SG, Haan J, Eikelenboom P, Roos RAC. Microglia in diffuse plaques in hereditary cerebral hemorrhage with amyloidosis (Dutch). An immunohistochemical study. J Neuropathol Exp Neurol 1994;53:483-91
45. Yamada M, Itoh Y, Shintaki M, et al. Immune reactions associated with cerebral amyloid angiopathy. Stroke 1996;27:1155-62
46. Yankner BA, Duffy LK, Kirschner DA. Neurotrophic and neurotoxic effects of amyloid protein: Reversal by tachykinin neuropeptides. Science 1990;250:279-82
47. Kowall NW, Beal MF, Busciglio J, Duffy LK, Yankner BA. An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc Natl Acad Sci USA 1991;88:7247-51
48. Lorenzo A, Yankner BA. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc Natl Acad Sci USA 1994;91:12243-47
49. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J Neurosci 1993;13:1676-87
50. McGeer PL, Kawamata T, Walker DG. Distribution of clusterin in Alzheimer brain tissue. Brain Res 1992;579:337-41
51. Meda L, Cassatella MA, Szendrei GI, et al. Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 1995;374:647-50
52. Canning DR, McKeon RJ, DeWitt DA, et al. β-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth. Exp Neurol 1993;124:289-98
53. Kimura T, Hashimura T, Miyakawa T. Observations of microvessels in the brain with Alzheimer's disease by the scanning electron microscope. Jpn J Psychiatr Neurol 1991;45:671-76
54. Kawai M, Kalaria RN, Cras P, et al. Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res 1993;623:142-46
55. Davis-Salinas J, Van Nostrand WE. Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells. J Biol Chem 1995;270:20887-90
56. Davis J, Van Nostrand WE. Enhanced pathologic properties of Dutch-type mutant amyloid β-protein. Proc Natl Acad Sci USA 1996;93:2996-3000
57. Snow AD, Mar H, Nochlin D, et al. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am J Pathol 1990;137:1253-70
58. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeld-Jakob disease. Brain Res 1991;541:163-66
59. Eikelenboom P, Stam FC. Immunoglobulins and complement factors in senile plaques. An immunohistochemical study. Acta Neuropathol 1982;57:239-42
60. Abraham CR, Selkoe DJ, Potter H. Immunochemical identification of the serine protease inhibitor alpha-1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 1988;52:487-501
61. Rozemuller JM, Abbink JJ, Kamp AM, Stam FC, Hack CE, Eikelenboom P. Distribution pattern and functional state of 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. Acta Neuropathol 1991;82:200-207
62. Zhan S-S, Veerhuis R, Kamphorst W, Eikelenboom P. Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly. Neurodegeneration 1995;4:291-97
63. Kalaria RN, Perry G. Amyloid P component and other acute-phase proteins associated with cerebellar Aβ-deposits in Alzheimer's disease. Brain Res 1993;631:151-55
64. Duong T, Pommier EC, Schiebel AB. Immunodetection of the amyloid P component in Alzheimer's disease. Acta Neuropathol 1989;78:429-37
65. Verbeek MM, Otte-Höller I, Westphal JR, Wesseling P, Ruiter DJ, de Waal RMW. Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer's disease. Am J Pathol 1994;144:104-16
66. Rozemuller JM, Bots GTAM, Roos RAC, Eikelenboom P. Acute phase proteins but not activated microglial cells are present in parenchymal β/A4 deposits in the brains of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type. Neurosci Lett 1992;140:137-40
67. van Duinen SG, Maat-Schieman MLC, Bruijn JA, Haan J, Roos RAC. Cortical tissue of patients with hereditary cerebral hemorrhage with amyloidosis (Dutch) contains various extracellular matrix deposits. Lab Invest 1995;73:183-89
68. Verbeek MM, Otte-Höller I, Wesseling P, Ruiter DJ, de Waal RMW. Differential expression of intercellular adhesion molecule-1 (ICAM-1) in the Aβ-containing lesions in brains of patients with dementia of the Alzheimer type. Acta Neuropathol 1996;91:608-15
69. Snow AD, Sekiguchi RT, Nochlin D, Kalaria RN, Kimata K. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. Am J Pathol 1994;144:337-47
70. Rozemuller JM, Stam FC, Eikelenboom P. Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease. Neurosci Lett 1990;119:75-78
71. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-81
72. Ghiso J, Matsubara E, Koudinov A, et al. The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP40,40 (apolipoprotein J), an inhibitor of the compement membrane attack complex. Biochem J 1993;293:27-30
73. Webster S, O'Barr S, Rogers J. Enhanced aggregation and structure of amyloid β peptide after coincubation with C1q. J Neurosci Res 1994;39:448-56
74. Fraser PE, Nguyen JT, McLachlan DR, Abraham CR, Kirschner DA. 1-Antichymotrypsin binding to Alzheimer Aβ peptides is sequence specific and induces fibril disaggregation in vitro. J Neurochem 1993;61:298-305
75. Snow AD, Kinsella MG, Parks E, et al. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease. Arch Biochem Biophys 1995;320:84-95
76. Ma J, Yee A, Brewer BJ, Das S, Potter H. Amyloid associated proteins 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 1994;372:92-94
77. Snow AD, Sekiguchi R, Nochlin D, et al. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain. Neuron 1994;12:219-34
78. Eikelenboom P, Veerhuis R. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Neurobiol Aging 1996;17:673-80
79. Kalaria RN, Kroon SN. Complement inhibitor C4-binding protein in amyloid deposits containing serum amyloid P in Alzheimer's disease. Biochem Biophys Res Commun 1992;186:461-66
80. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:9649-53
81. Greenberg SM, Rebeck GW, Vonsattel J-P, Gomez-Isla T, Hyman BT. Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995;38:254-59
82. Premkumar DRD, Cohen DL, Hedera P, Friedland RP, Kalaria RN. Apolipoprotein E-ε4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 1996;148:2083-95
83. Narindrasorasak S, Altman RA, Gonzalez-DeWhitt P, Greenberg BD, Kisilevsky R. An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease. Lab Invest 1995;72:272-82
84. Perlmutter LS, Barrón E, Saperia D, Chui HC. Association between vascular basement membrane components and the lesions of Alzheimer's disease. J Neurosci Res 1991;30:673-81
85. Greenberg SM, Briggs ME, Hyman BT, et al. Apolipoprotein E ε4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke 1996;27:1333-37
86. Nicoll JAR, Burnett C, Love S, Graham DI, Ironside JW, Vinters HV. High frequency of apolipoprotein E ε2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1996;39:682
87. Risau W, Dingler A, Albrecht U, Dehouck MP, Cecchelli R. Blood-brain barrier pericytes are the main source of β-glutamyl transpeptidase activity in brain capillaries. J Neurochem 1992;98:667-72
88. Kalaria RN. The blood-brain barrier and cerebral microcirculation in Alzheimer's disease. Cerebrovasc Brain Metab Rev 1992;4:226-60